Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Who decides the cost of medicines in India?

India’s separation of medicine licensing under CDSCO and pricing under NPPA presents a policy challenge. Stronger coordination,supported by pharmaceutical, clinical and health-economic expertise, could bridge this gap

Who decides the cost of medicines in India?

We haven't written up this one. The Hindu Health has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at thehindu.com →

More in Health & Medicine

GC Biopharma Signs VaxThera Vaccine Deal

Contract Worth About KRW 59.2 Billion Backed by RIGHT Foundation Funding GC Biopharma said on Nov. 2 that it signed a contract with VaxThera, a Colombian vaccine company, for technical support for…

  • GC Biopharma signs KRW 59.2 billion deal with VaxThera for influenza vaccine production.
  • GC Biopharma supplies bulk drug substance and process technology support.
  • VaxThera manages filling, packaging, quality control, and local distribution.

More from Monday 2 November →